|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,350 KRW | -0.47% |
|
+3.25% | +4.10% |
Bukwang Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was KRW 28.19 million. Net loss was KRW 2,120.42 million compared to KRW 3,216.47 million a year ago.
Basic loss per share from continuing operations was KRW 39 compared to KRW 52 a year ago. Diluted loss per share from continuing operations was KRW 39 compared to KRW 52 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.10% | 321M | |
| +21.03% | 43.48B | |
| +20.67% | 22.65B | |
| +14.56% | 14.73B | |
| +13.78% | 13.79B | |
| +43.93% | 12.04B | |
| -8.37% | 7.08B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +11.90% | 5.47B |
BUKWANG PHARMACEUTICAL CO., LTD. 